Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up. BMC Med Phys 2009 May 05;9:5 PMID: 19416541 PMCID: PMC2686669

Pubmed ID

19416541

Abstract

BACKGROUND: Light chain amyloidosis (AL) is a rare plasma cell dyscrasia associated with poor survival especially in the setting of heart failure. Late gadolinium enhancement (LGE) on cardiac MRI was recently found to correlate with myocardial amyloid deposition but the prognostic role is not established. The aim is to determine the prognostic significance of LGE in AL by comparing long term survival of AL patients with and without LGE.

METHODS: Twenty nine consecutive patients (14 females; 62 +/- 11 years) with biopsy-proven AL undergoing cardiac MRI with gadolinium as part of AL workup were included. Survival was prospectively followed 29 months (median) following MRI and compared between those with and without LGE by Kaplan-Meier and log-rank analyses.

RESULTS: LGE was positive in 23 subjects (79%) and negative in 6 (21%). Left ventricular ejection fraction was 66 +/- 17% in LGE-positive and 69 +/- 12% in LGE-negative patients (p = 0.8). Overall 1-year mortality was 36%. On follow-up, 14/23 LGE-positive and none of LGE-negative patients died (log rank p = 0.0061). Presenting New York Heart Association heart failure class was also associated with poor survival (p = 0.0059). Survival between two LGE groups stratified by heart failure class still showed a significant difference by a stratified log-rank test (p = 0.04).

CONCLUSION: Late gadolinium enhancement is common and is associated with poor long-term survival in light chain amyloidosis, even after adjustment for heart failure class presentation. The prognostic significance of late gadolinium enhancement in this disease may be useful in patient risk-stratification.

Author List

Migrino RQ, Christenson R, Szabo A, Bright M, Truran S, Hari P

Authors

Parameswaran Hari MD Chief, Professor in the Medicine department at Medical College of Wisconsin
Aniko Szabo PhD Associate Professor in the Institute for Health and Equity department at Medical College of Wisconsin




jenkins-FCD Prod-300 626508253d14e4184314fb9f66322a03a5906796